Might be time to hang up the boots mate and sell your holding if you are really this disappointed in PYC and are confident they are heading south. Revenue is not something really considered with a Bio in development. More about successful data & safety and enough interest to generate sufficient funds to have on hand for which they found much interest not so long ago from institutional investors and existing holders, not to mention companies like Lions. Understand your concerns and I have held this stock for longer than yourself and yes, it does get frustrating but its either stay onboard for a possibility of a drug to come to market, or a partnership, or move on to other things.
NICE DAY TODAY, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.020(11.1%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 20.5¢ | 18.0¢ | $1.219M | 6.294M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 106194 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 184767 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |